These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8515861)

  • 1. Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum.
    Vizuete ML; Steffen V; Ayala A; Cano J; Machado A
    Neurosci Lett; 1993 Apr; 152(1-2):113-6. PubMed ID: 8515861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR; Zhu ZT; Zhu XZ
    Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
    Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
    Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo.
    Wu RM; Chiueh CC; Pert A; Murphy DL
    Eur J Pharmacol; 1993 Oct; 243(3):241-7. PubMed ID: 8276076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.
    Wu RM; Murphy DL; Chiueh CC
    J Neural Transm Gen Sect; 1995; 100(1):53-61. PubMed ID: 8748663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
    Castagnoli K; Palmer S; Castagnoli N
    Neurobiology (Bp); 1999; 7(2):135-49. PubMed ID: 10591048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity.
    Thiffault C; Quirion R; Poirier J
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):127-36. PubMed ID: 9387872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
    Wu RM; Chen RC; Chiueh CC
    Ann N Y Acad Sci; 2000; 899():255-61. PubMed ID: 10863544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant.
    Seif-El-Nasr M; Atia AS; Abdelsalam RM
    Arzneimittelforschung; 2008; 58(4):160-7. PubMed ID: 18540477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia.
    Knollema S; Aukema W; Hom H; Korf J; ter Horst GJ
    Stroke; 1995 Oct; 26(10):1883-7. PubMed ID: 7570743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Mytilineou C; Cohen G
    J Neurochem; 1985 Dec; 45(6):1951-3. PubMed ID: 3932598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hydroxyl radical formation and protection of nigral neurons by l-deprenyl (selegiline).
    Wu RM; Murphy DL; Chiueh CC
    Ann N Y Acad Sci; 1996 Jun; 786():379-90. PubMed ID: 8687036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprenyl prevents MPP(+)-induced oxidative damage in PC12 cells by the upregulation of Nrf2-mediated NQO1 expression through the activation of PI3K/Akt and Erk.
    Xiao H; Lv F; Xu W; Zhang L; Jing P; Cao X
    Toxicology; 2011 Dec; 290(2-3):286-94. PubMed ID: 22019741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity.
    Rojas P; Rojas C; Ebadi M; Montes S; Monroy-Noyola A; Serrano-García N
    Neurochem Res; 2004 Jul; 29(7):1417-23. PubMed ID: 15202774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy.
    Kitani K; Minami C; Yamamoto T; Maruyama W; Kanai S; Ivy GO; Carrillo MC
    Ann N Y Acad Sci; 2001 Apr; 928():248-60. PubMed ID: 11795516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats.
    Carrillo MC; Kanai S; Nokubo M; Kitani K
    Life Sci; 1991; 48(6):517-21. PubMed ID: 1899460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.